Company Overview

Niox Group PLC (ticker: NIOX.L) is a pharmaceutical company focused on the development of treatments and diagnostics for asthma. The company is listed on the London Stock Exchange and can be accessed via its website at www.niox.com .

Recent Share Performance

  • Closing price (23 Oct 2026, 01:33 PM CET): GBX 66.79
  • Daily change: ‑4.35 % (24‑hour period)
  • Market capitalization: GBX 480.3 million
  • 24‑hour volume: GBX 29.6 million
  • 200‑day simple moving average: GBX 63.07
  • 52‑week high (27 Nov 2025): GBX 74.43
  • 52‑week low (23 Mar 2026): GBX 53.84

Corporate Actions

Niox Group PLC announced the following actions:

  1. Block‑listing arrangements related to completed share‑scheme plans have been cancelled. The outstanding options under these schemes were either exercised or lapsed.
  2. Tender offer: Approximately 50 % of the company’s ordinary shares were tendered in a recent offer. The company purchased up to the maximum allotment at a price set by the board. The tendered shares were cancelled, reducing the share base while maintaining a substantial marketable portion.
  3. Director confirmation: The directors verified that the tender terms were fair.
  4. Related‑party disclosure: A transaction involving a major shareholder was disclosed and deemed compliant with regulatory requirements.
  5. Shareholder return: The proceeds from the tender offer will be returned to shareholders by the end of October. Additional related‑party disclosures will be made subsequently.
Symbol24‑Hour ChangeCurrent Price (GBX)Market Capitalisation (GBX mn)
NFG.L (Next)+4.02 %325.00572.4
TTG.L (Tt Electronics)+2.88 %184.60574.6
AVCT.L (Avacta)–3.81 %63.81556.4
YOU.L (Yougov)–0.35 %273.60574.8
FSTA.L (Fuller Smith & Turner)–0.26 %785.02556.4

Additional Ratios

  • Yougov: Price‑to‑earnings ratio 58.99
  • Fuller Smith & Turner: Price‑to‑earnings ratio 20.37

Summary

Niox Group PLC experienced a 4.35 % decline in share price during the 24‑hour period ending at 01:33 PM CET on 23 Oct 2026. The company’s market capitalisation stands at GBX 480.3 million, with a 200‑day moving average of GBX 63.07. Recent corporate actions include the cancellation of block‑listing arrangements, a large‑scale tender offer that reduced the share base, and compliance‑checked related‑party transactions. The company plans to return tender proceeds to shareholders by the end of October.